AIM Clinical Appropriateness Guidelines and Cancer Treatment Pathways
The AIM Specialty Health Clinical Appropriateness Guidelines and Cancer Treatment Pathways are clinical tools designed to help providers choose the most appropriate treatments and tests for health plan members with complex clinical needs.
Guidelines for genetic testing, including for pharmacogenomics, prenatal diagnosis, cardiac disease, cancer susceptibility, and tumors and malignancies.
Cancer treatment pathways for common types of cancer, including breast cancer, colorectal cancer, prostate cancer, melanoma, lung cancer, and lymphoma.